Kelly Brauer, MD
Allergy & Immunology · Owensboro, KYNPI 1639376296
Payments from drug & device makers
Across 659 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Alk-abello, Inc$2K
- GSK$2K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Amgen$593
- plus $5K from 28 others
What the payments were for
- Speaking & faculty fees$1,40010%
- Food & beverage$12,71389%
- Education$1621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 131 | $3,036 |
| Alk-abello, Inc | 13 | $1,660 |
| GSK | 91 | $1,537 |
| Sanofi | 88 | $1,467 |
| Regeneron Healthcare Solutions, Inc. | 62 | $1,389 |
| Amgen | 33 | $593 |
| Kaleo, Inc. | 29 | $537 |
| Teva Pharmaceuticals USA, Inc. | 36 | $487 |
| Genentech USA, Inc. | 16 | $477 |
| CSL Behring | 23 | $465 |
| Optinose US, Inc. | 25 | $421 |
| Octapharma USA, Inc. | 10 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $261 |
| Pfizer | 14 | $256 |
| Boehringer Ingelheim | 14 | $225 |
| Novartis | 9 | $195 |
| Blueprint Medicines Corporation | 7 | $154 |
| Hikma Pharmaceuticals USA | 8 | $147 |
| Shire North American Group Inc | 2 | $139 |
| AbbVie | 7 | $122 |
| Sanofi-aventis U.S. LLC | 1 | $64 |
| Galderma Laboratories, L.p. | 1 | $43 |
| Lilly USA, LLC | 2 | $41 |
| ADMA Biomanufacturing LLC | 1 | $39 |
| Verona Pharma, Inc. | 2 | $37 |
| LEO Pharma Inc. | 2 | $35 |
| Covis Pharma GmbH | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| X4 Pharmaceuticals, Inc. | 1 | $27 |
| Mylan Specialty L.p. | 1 | $22 |
| Biocryst US Sales Co., LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Pharming Healthcare, Inc. | 1 | $16 |
| Ionis Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,275 in reported general payments places this provider in the 65th percentile of 66 allergy & immunology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $117,450 |
| Dupixent SyringeDupilumab | 14 | $54,614 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $17,490 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $13,883 |
| Spiriva RespimatTiotropium Bromide | 25 | $12,284 |
| Epinephrine | 46 | $10,601 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 69 | $7,816 |
| Cromolyn Sodium | 25 | $7,183 |
| Qvar RedihalerBeclomethasone Dipropionate | 14 | $5,422 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,307 |
| Arnuity ElliptaFluticasone Furoate | 19 | $4,219 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $4,121 |
| Azelastine Hcl | 182 | $3,615 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $3,319 |
| Levocetirizine Dihydrochloride | 190 | $2,413 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta | $1,537 | $21,70958 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $3,036 | $18,19038 claims |
| Boehringer IngelheimSpiriva Respimat | $225 | $12,28425 claims |
| Hikma Pharmaceuticals USAEpinephrine | $147 | $10,60146 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $487 | $5,42214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 66 allergy & immunology providers in Kentucky.
Other allergy & immunology in Owensboro
- Lee CloreOwensboro$3.7M
- William GreisnerLexington$1.8M
- James SublettLouisville$1.7M
- Manuel VillarealLakeside Park$533K
- James SublettLouisville$481K
- Stephen PollardLouisville$463K
- Hans OttoFlorence$381K
- Douglas LotzLouisville$199K
- Timothy FranxmanLouisville$162K
- Jeremy JonesLouisville$149K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.